{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:12:48Z","timestamp":1780546368055,"version":"3.54.1"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2011,12,2]],"date-time":"2011-12-02T00:00:00Z","timestamp":1322784000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0028182","type":"journal-article","created":{"date-parts":[[2011,12,3]],"date-time":"2011-12-03T19:13:33Z","timestamp":1322939613000},"page":"e28182","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":33,"title":["Measurement of Warfarin in the Oral Fluid of Patients Undergoing Anticoagulant Oral Therapy"],"prefix":"10.1371","volume":"6","author":[{"given":"Silvia","family":"Ghimenti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Lomonaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Onor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Murgia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Paolicchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Fuoco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Ruocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giovanna","family":"Trivella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Di Francesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,12,2]]},"reference":[{"key":"ref1","article-title":"Pharmacy Times, Top 200 Prescription Drugs of 2007."},{"key":"ref2","article-title":"Basic & clinical pharmacology","author":"BG Katzung","year":"2000"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/archinte.1993.00410130073007","article-title":"Bleeding complications in oral anticoagulant therapy. An analysis of risk factors.","volume":"153","author":"FJ Van der Meer","year":"1993","journal-title":"Arch Intern Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1753-4887.1999.tb01815.x","article-title":"Vitamin K: a practical guide to the dietary management of patients on warfarin.","volume":"57","author":"SL Booth","year":"1999","journal-title":"Nutr Rev"},{"key":"ref5","first-page":"77","article-title":"Controlled vitamin K content diet for improving the management of poorly controlled anticoagulated patients: a clinical practice proposal.","volume":"23","author":"GG Sorano","year":"1993","journal-title":"Haemostasis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"676","DOI":"10.7326\/0003-4819-121-9-199411010-00009","article-title":"Interactions of warfarin with drugs and food.","volume":"121","author":"PS Wells","year":"1994","journal-title":"Ann Intern Med"},{"key":"ref7","first-page":"1633","article-title":"American Heart Association\/ American College of Cardiology Foundation guide to warfarin therapy.","volume":"41","author":"J Hirsh","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0002-9343(00)00545-3","article-title":"Management and dosing of warfarin therapy.","volume":"109","author":"BF Gage","year":"2000","journal-title":"Am J Med"},{"key":"ref9","first-page":"1","article-title":"Guidelines for thromboplastins and plasma used to control oral anticoagulant therapy.","volume":"889","year":"1999","journal-title":"World Health Organ Tech Rep Ser"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/jama.281.2.145","article-title":"A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial.","volume":"281","author":"PT Sawicki","year":"1999","journal-title":"J Am Med Assoc"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"730","DOI":"10.7326\/0003-4819-111-9-730","article-title":"Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study.","volume":"111","author":"RH White","year":"1989","journal-title":"Ann Intern Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1001\/archinte.1993.00410120027004","article-title":"Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy.","volume":"153","author":"DR Anderson","year":"1993","journal-title":"Arch Intern Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1160\/TH08-06-0361","article-title":"Self-management of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial.","volume":"100","author":"A Siebenhofer","year":"2008","journal-title":"Thromb Haemost"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0140-6736(06)68139-7","article-title":"Self-monitoring of oral anticoagulation: a systematic review and meta-analysis.","volume":"367","author":"C Heneghan","year":"2006","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/00003088-197803010-00003","article-title":"Therapeutic drug monitoring in saliva.","volume":"3","author":"M Danhof","year":"1978","journal-title":"Clin Pharmacokinet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/cpt1978245563","article-title":"Drug concentration in saliva.","volume":"24","author":"JC Mucklow","year":"1978","journal-title":"Clin Pharmacol Ther"},{"key":"ref17","first-page":"11","article-title":"Measurements of drugs in saliva: a review.","volume":"1","author":"JW Paxton","year":"1979","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"ref18","first-page":"208","article-title":"Saliva, an alternative specimen in clinical chemistry.","volume":"2","author":"R Haeckel","year":"1990","journal-title":"J Int Fed Clin Chem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0378-4347(97)00572-0","article-title":"Testing for drugs of abuse in saliva and sweat.","volume":"713","author":"DA Kidwell","year":"1998","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF01066216","article-title":"Protein binding of warfarin enatiomers in serum of human and rat.","volume":"5","author":"A Yacobi","year":"1977","journal-title":"J Pharmacokinetic Biopharm"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/cpt19741661052","article-title":"Pharmacokinetics of tolbutamide: prediction by concentration in saliva.","volume":"16","author":"SB Matin","year":"1974","journal-title":"Clin Pharmacol Ther"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0021-9673(01)96463-5","article-title":"Analysis of warfarin and its metabolites by reversed-phase ion-pair liquid chromatography with fluorescence detection.","volume":"469","author":"YWJ Wong","year":"1989","journal-title":"J Chromatogr A"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0584-8547(78)80044-5","article-title":"Nomenclature, symbols, units and their usage in spectrochemical analysis\u2013II.","volume":"33","year":"1978","journal-title":"Spectrochim Acta Part B At Spectrosc"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/14786440109462720","article-title":"On lines and planes of closest fit to systems of points in space.","volume":"2","author":"K Pearson","year":"1901","journal-title":"Philosophical Magazine"},{"key":"ref25","article-title":"Principal Component Analysis, 2nd Ed","author":"IT Jolliffe","year":"2002"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/archinte.165.10.1095","article-title":"Systematic overview of warfarin and its drug and food interactions.","volume":"165","author":"AM Holbrook","year":"2005","journal-title":"Arch Intern Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00008571-199512000-00008","article-title":"Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirements in patients undergoing anticoagulant therapy.","volume":"5","author":"H Furuya","year":"1995","journal-title":"Pharmacogenetics"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(98)04474-2","article-title":"Association of polymorphism in the cytochrome P450 CYP2C9 with warfarin dose requirements and risk of bleeding complications.","volume":"353","author":"GP Aithal","year":"1999","journal-title":"Lancet"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1067\/mcp.2002.129321","article-title":"Influence of CYP2C9 and CYP2C19 genetic polymorphism on warfarin maintenance dose and metabolic clearance.","volume":"72","author":"MG Scordo","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/cpt1970114524","article-title":"Displacement of warfarin from human albumin by diazoxide and ethacrynic, mefenamic, and nalidixic acids.","volume":"11","author":"EM Sellers","year":"1970","journal-title":"Clin Pharmacol Ther"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.thromres.2003.09.006","article-title":"Measurement of warfarin in plasma by high performance liquid chromatography (HPLC) and its correlation with the international normalized ratio.","volume":"111","author":"R Lombardi","year":"2003","journal-title":"Thromb Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cca.2008.03.008","article-title":"Measurement of free concentrations of highly protein-bound warfarin in plasma by ultra performance liquid chromatography\u2013tandem mass spectrometry and its correlation with the international normalized ratio.","volume":"393","author":"C Huang","year":"2008","journal-title":"Clin Chim Acta"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0028182","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T07:40:21Z","timestamp":1561016421000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0028182"}},"subtitle":[],"editor":[{"given":"Pieter H.","family":"Reitsma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,12,2]]},"references-count":32,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2011,12,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0028182","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,2]]}}}